Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Spirax reports better-than-expected first half, shares pop

(Sharecast News) - Spirax Group reported first-half results that exceeded analyst expectations on Tuesday, sending shares soaring, as the company reaffirmed full-year guidance despite macroeconomic headwinds. For the six months ended 30 June, group revenue fell 1% to £822.2m on a reported basis but rose 3% organically, outpacing global industrial production growth.

Adjusted operating profit was broadly flat at £158.8m, up 7% organically, with margins improving to 19.3% organically.

Statutory operating profit fell 27% to £106.8m, reflecting restructuring costs and currency headwinds, while profit before tax dropped 30% to £87.9m.

The FTSE 100 company lifted its interim dividend 3% to 48.9p.

It said its electric thermal solutions division led growth with a 10% organic increase, aided by stronger semiconductor demand, while Watson-Marlow Fluid Technology Solutions grew 2% organically, with biopharma orders up more than 10%.

Steam thermal solutions sales were flat but ahead of expectations, particularly outside China.

Management said it was expecting second-half sales growth to accelerate, margins to improve and cash conversion to exceed 80%.

CEO Nimesh Patel said results were "in line with expectations despite the challenging macroeconomic environment," citing strong order books and progress on operational priorities as support for the unchanged outlook.

He added that efficiency programmes were funding investment in "digital and decarbonisation" initiatives.

Analysts described the update as resilient.

Jefferies said the results were ahead of consensus and highlighted "stand-out" performance in electric thermal solutions.

RBC Capital Markets noted the beat across all divisions and said the outcome "helps de-risk unchanged full-year guidance," though it cautioned on ongoing steam market weakness in China.

Citi said order momentum in Watson-Marlow and the turnaround in electric thermal solutions could offer "upside potential to consensus," while Shore Capital said the figures boosted confidence despite macro and currency risks.

At 0905 BST, shares in Spirax Group were up 15.01% at 6,969.48p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.